Literature DB >> 9661840

Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction.

N Chadwick1, I J Bruce, S Schepelmann, R E Pounder, A J Wakefield.   

Abstract

Recent epidemiological and immunohistochemical studies have indicated a possible link between measles virus and inflammatory bowel disease (IBD). The aim of this study was to use a sensitive and robust method for the detection of measles virus RNA in IBD and control clinical samples. Peripheral blood mononuclear cells and intestinal resection tissue from IBD and control patients were studied. Two methods were used to determine the presence of measles virus RNA: hybrid capture, using measles virus-specific oligonucleotides linked to paramagnetic solid-phase supports, was carried out on total cellular RNA to enrich for measles virus RNA sequences. Reverse transcription followed by the polymerase chain reaction (RT-PCR) using rTth DNA polymerase was employed for amplification of measles virus N-gene sequences amongst the enriched species. Total RNA was also used for RT-PCR of a housekeeping mRNA species to assess RNA quality. RT-PCR for another region of the measles genome (the haemagglutinin (H) gene) was also undertaken in order to confirm the results obtained using N-gene primers for analysis of these samples. None of the samples were positive for measles N- or H-gene RNA using RT-PCR. Positive control samples confirmed the sensitivity of the methods employed. These results show that either measles virus RNA was not present in the samples, or was present below the sensitivity limits known to have been achieved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661840

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  No evidence of persistent mumps virus infection in inflammatory bowel disease.

Authors:  M Iizuka; H Saito; M Yukawa; H Itou; T Shirasaka; M Chiba; T Fukushima; S Watanabe
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  MMR vaccine--worries are not justified.

Authors:  D A Elliman; H E Bedford
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 4.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  Measles virus persistence in specimens of inflammatory bowel disease and autism cases.

Authors:  M A Afzal; P D Minor; S Ghosh; L Jin
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 6.  MMR vaccination and autism : what is the evidence for a causal association?

Authors:  Kreesten M Madsen; Mogens Vestergaard
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

8.  Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.

Authors:  M Iizuka; M Chiba; M Yukawa; T Nakagomi; T Fukushima; S Watanabe; O Nakagomi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 9.  Measles, mumps and rubella vaccine, autism and inflammatory bowel disease: advising concerned parents.

Authors:  David A C Elliman; Helen E Bedford
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

10.  Detection of species-specific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis.

Authors:  C J Streutker; C N Bernstein; V L Chan; R H Riddell; K Croitoru
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.